Natus Medical reported $41.61M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abiomed ABMD:US $ 102.78M 705K
Accuray ARAY:US $ 22.73M 1.5M
Atricure ATRC:US $ 49.87M 7.08M
Boston Scientific BSX:US $ 1.07B 55M
Cardiovascular Systems CSII:US $ 41.85M 3.86M
Cryolife CRY:US $ 39.05M 6.02M
Edwards Lifesciences EW:US $ 364.4M 10.1M
General Electric GE:US $ 2.64B 80M
Genmark Diagnostics GNMK:US $ 12.4M 2.06M
Globus Medical GMED:US $ 96.44M 10.81M
Hill Rom HRC:US $ 238.4M 35.9M
Inogen INGN:US $ 37.56M 3.02M
Insulet PODD:US $ 117.5M 1.2M
Integra Lifesciences IART:US $ 149.62M 6.36M
Koninklijke Philips PHG:US 1.2B 11M
Masimo MASI:US $ 100.65M 6.81M
Mesa Laboratories MLAB:US $ 16.33M 49K
Natus Medical BABY:US $ 41.61M 485K
Orthofix International OFIX:US $ 72.41M 3.26M
Perkinelmer PKI:US $ 339.05M 67.83M
Philips PHIA:NA 1.2B 11M
Surmodics SRDX:US $ 7.86M 20K
Tandem Diabetes Care TNDM:US $ 64.92M 1.6M
Thermo Fisher Scientific TMO:US $ 1.73B 214M